AbCellera Biologics Inc. ABCL Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s total operating expenses?
- AbCellera Biologics Inc. (ABCL) reported total operating expenses of $65.83M in Q1 2026.
- How has AbCellera Biologics Inc.'s total operating expenses changed year-over-year?
- AbCellera Biologics Inc.'s total operating expenses decreased by 1.6% year-over-year, from $66.9M to $65.83M.
- What is the long-term trend for AbCellera Biologics Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s total operating expenses has grown at a 14.4% compound annual growth rate (CAGR), from $170.73M to $292.23M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.